nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adverse Events to SARS-CoV-2 (COVID-19) Vaccines and Policy Considerations that Inform the Funding of Safety Surveillance in Low- and Middle-Income Countries: A Mixed Methods Study
|
Ogar, Comfort K. |
|
|
46 |
4 |
p. 357-370 |
artikel |
2 |
Cohort Event Monitoring of Adverse Reactions to COVID-19 Vaccines in Seven European Countries: Pooled Results on First Dose
|
Raethke, Monika |
|
|
46 |
4 |
p. 391-404 |
artikel |
3 |
Conference on Advances in Pharmacovigilance for Herbal Medicines 12th–14th April 2023
|
|
|
|
46 |
4 |
p. 419-431 |
artikel |
4 |
Correction to: Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review
|
Kompa, Benjamin |
|
|
46 |
4 |
p. 433 |
artikel |
5 |
Early Detection of Adverse Drug Reaction Signals by Association Rule Mining Using Large-Scale Administrative Claims Data
|
Yamamoto, Hiroki |
|
|
46 |
4 |
p. 371-389 |
artikel |
6 |
Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends
|
Ly, Nelly F. |
|
|
46 |
4 |
p. 405-416 |
artikel |
7 |
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System
|
Crisafulli, Salvatore |
|
|
46 |
4 |
p. 343-355 |
artikel |
8 |
Preventable Deaths Involving Medicines: A Systematic Case Series of Coroners’ Reports 2013–22
|
France, Harrison S. |
|
|
46 |
4 |
p. 335-342 |
artikel |
9 |
Real-World Monitoring of COVID-19 Vaccines: An Industry Expert View on the Successes, Challenges, and Future Opportunities
|
Bauchau, Vincent |
|
|
46 |
4 |
p. 327-333 |
artikel |
10 |
The Rationale for Robust Pharmacovigilance in Monitoring the Safety of Traditional Medicines and Natural Health Products
|
Braund, Rhiannon |
|
|
46 |
4 |
p. 417-418 |
artikel |